We are live on ! Find out more

TBXU

Direxion Daily Biotech Top 5 Bull 2X ETF

TBXU

Market cap $5.55M

44.38 USD

-1.38

3.02%

At close Updated Sep 4, 4:00 PM EDT

1 day

-3.02%

5 days

4.06%

1 month

27.82%

3 months

51.31%

6 months

27.24%

Year to date

43.58%

1 year

66.59%

5 years

66.59%

10 years

66.59%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 0%

Negative 0%

Remember the Titans ETFs For Opportunities in 2026

In October 2025, Direxion Investments welcomed a new family of ETFs into their ever-growing roster of leveraged and inverse funds: the Titans ETFs. The suite of funds essentially give traders a middle ground when deciding between broad sector exposure and single-stock opportunities.

Remember the Titans ETFs For Opportunities in 2026

Remember the Titans ETFs For Opportunities in 2026

In October 2025, Direxion Investments welcomed a new family of ETFs into their ever-growing roster of leveraged and inverse funds: the Titans ETFs. The suite of funds essentially give traders a middle ground when deciding between broad sector exposure and single-stock opportunities.

Remember the Titans ETFs For Opportunities in 2026

New FDA Director Could Sway Biotech ETFs

Biotech stocks could sway toward the upside with the appointment of a new director at the Federal Drug Administration's Center for Drug Evaluation and Research. Dr. Richard Pazdur will take the reigns, bringing 26 years of related industry experience.

New FDA Director Could Sway Biotech ETFs

Trade Top 5 Industry Leaders With Direxion's New Titans ETFs

Direxion expanded its existing product lineup of leveraged and inverse exchange-traded funds (ETFs) with a new suite: the Titans Leveraged & Inverse ETFs. The funds offer a middle-ground approach that eschews the concentration risk inherent in single-stocks ETFs.

Trade Top 5 Industry Leaders With Direxion's New Titans ETFs

Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs

New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of funds designed to give active traders precise exposure to the top five companies in key U.S. sectors and industries.

Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs

See News Rankings

Price charts implemented using Lightweight Charts™